Back
Arcutis Biotherapeutics Vs. AbbVie Industry Stock Comparison
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.14
Seasonality Move:
-24.31%
Buy
51
ABBV
AbbVie
Last Price:
193.62
Seasonality Move:
8.43%
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $10.39. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
AbbVie (ABBV)
is a Buy
Is AbbVie a Buy, Sell or Hold?
- The current AbbVie [ABBV] share price is $192.94. The Score for ABBV is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- ABBV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $10.39
The current trend is moderately bearish and ARQT is experiencing slight buying pressure.
ABBV Stock Price Chart
ARQT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.23 | Buy |
Relative Strength Index (14 RSI): | 53.01 | Buy |
Chaikin Money Flow: | 469104 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.08 - 10.94) | Buy |
Bollinger Bands (100): | (8.33 - 10.29) | Buy |
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.44 | Buy |
Relative Strength Index (14 RSI): | 49.74 | Sell |
Chaikin Money Flow: | -1249780 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (193.69 - 197.17) | Sell |
Bollinger Bands (100): | (162.36 - 190.1) | Buy |
ARQT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.53 | Sell |
20-day SMA: | 10.33 | Buy |
50-day SMA: | 9.91 | Buy |
200-day SMA: | 8.15 | Buy |
8-day EMA: | 10.45 | Sell |
20-day EMA: | 10.28 | Buy |
50-day EMA: | 9.91 | Buy |
200-day EMA: | 8.95 | Buy |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 195.09 | Sell |
20-day SMA: | 195.62 | Sell |
50-day SMA: | 187.85 | Buy |
200-day SMA: | 171.86 | Buy |
8-day EMA: | 194.47 | Sell |
20-day EMA: | 194.16 | Sell |
50-day EMA: | 188.49 | Buy |
200-day EMA: | 172.9 | Buy |
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.
AbbVie Earnings Growth & ABBV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.25 per share, and an increase next year of $1.21 per share.
Arcutis Biotherapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
AbbVie Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |